FDA Investigator: Dongping Dai

- Dongping Dai first started conducting FDA inspections in 2008, with the last inspection in 2024. Over that time, Dongping Dai has conducted 34 inspections at 33 companies across 34 sites.

Get Dongping Dai's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Yung Shin Pharmaceutical Industry Co., Ltd., Taichung City | 2024

Out-of-stock
Dongping Dai
Human Drugs Form 483

FDA 483 Sun Pharmaceutical Industries, LTD., Halol | 2019

Out-of-stock
Dongping Dai
Human Drug Form 483

FDA 483 Merck Sharp & Dohme, Riom | 2014

Out-of-stock
Dongping Dai
Human Drug Form 483

FDA 483 Merck Sharp Dohme-Chibret, Riom, Clermont-Ferrand | 2014

Out-of-stock
Dongping Dai
Human Drug Form 483

FDA 483 Laboratoires Merck Sharp & Dohme Chibret, Riom | 2014

Out-of-stock
Dongping Dai
Human Drug Form 483

FDA 483 Novo Nordisk A/S, Gentofte | 2014

Out-of-stock
Dongping Dai
Human Drug Form 483

FDA 483 Laboratories Merck Sharp & Dohme - Chibret, Clermont-Ferrand Cedex | 2014

Out-of-stock
Dongping Dai
Human Drug Form 483

FDA 483 Warner Chilcott U.k. Limited, Larne | 2013

Out-of-stock
Dongping Dai
Human Drug Form 483

FDA 483 BASF Pharma (Callanish) Ltd., Isle of Lewis, Western Isles | 2013

Out-of-stock
Dongping Dai
Human Drug Form 483

FDA 483 Pharmalucence, Inc., Billerica | 2012

Out-of-stock
Dongping Dai
Human Drug Form 483

FDA 483 Drug Houses Of Australia Pte Ltd, Singapore | 2012

Out-of-stock
Dongping Dai
Human Drug Form 483